U.S. plans to roll out COVID-19 shots for children under 5 years in February

The U.S. Food and Drug Administration (FDA) is considering authorizing the use of the Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) vaccine in the age group even though it did not meet a key target in a clinical trial of two- to four-year-olds.
The drugmakers said they submitted data supporting authorization at the request of the FDA in order to address an urgent public health need in the age group. [ Source: Reuters (Read More…) ]
Worthy News reports from a biblical worldview with a commitment to accuracy, transparency, and editorial independence. Learn more about About Worthy News, our Editorial Standards, AI Use Policy, Ownership of Worthy News, News Tips and Corrections, and Worthy News Staff.
đź’ˇ Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌
